Cargando…

The association between corticosteroid uses and mortality among severe COVID-19 patients

Detalles Bibliográficos
Autores principales:	Tang, Hung-Jen, Lai, Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486875/ https://www.ncbi.nlm.nih.gov/pubmed/32931775 http://dx.doi.org/10.1016/j.jinf.2020.09.005

Ejemplares similares

The association between corticosteroids and aspergillosis among COVID-19 patients
por: Chang, Yi-Hsin, et al.
Publicado: (2023)

Corticosteroids for Non-severe COVID-19: Primum Non Nocere
por: Muthu, Valliappan, et al.
Publicado: (2022)

Decline in invasive pneumococcal disease during COVID-19 pandemic in Taiwan
por: Juan, Hui-Chun, et al.
Publicado: (2021)

In Response to: Corticosteroids in Non-severe COVID-19: Finding Window of Opportunity
por: Nasa, Prashant, et al.
Publicado: (2022)

More efforts to explore the association between cirrhosis and COVID-19 mortality, and the association between NAFLD and severe COVID-19
por: Li, Zheng, et al.
Publicado: (2022)

The implementation of an active surveillance integrating information technology and drive-through coronavirus testing station for suspected COVID-19 cases
por: Chen, Hung-Jui, et al.
Publicado: (2021)

A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022)

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19
por: Goursaud, Suzanne, et al.
Publicado: (2020)

Corticosteroids and rehabilitation in COVID-19 survivors
por: Lal, Amos, et al.
Publicado: (2021)

Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
por: Nakajima, Kento, et al.
Publicado: (2021)

A meta-analysis of the association between calprotectin and the severity of COVID-19
por: Mao, Qin, et al.
Publicado: (2022)

What can we learn about corticosteroid therapy as a treatment for COVID-19?
por: Tang, J.
Publicado: (2020)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021)

Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients
por: Chen, Ping-Jen, et al.
Publicado: (2021)

Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy—a case report
por: Hu, Zhiliang, et al.
Publicado: (2020)

The clinical efficacy of lefamulin in the treatment of elderly patients with community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors
por: Hsu, Wan-Hsuan, et al.
Publicado: (2023)

Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021)

Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate
por: Chaudhry, Zain, et al.
Publicado: (2021)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
por: Shokri, Somayeh, et al.
Publicado: (2022)

Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?
por: FakhriRavari, Alireza, et al.
Publicado: (2021)

Severe complicated influenza declined during the prevention of COVID-19 in Taiwan
por: Yang, Chih-Jen, et al.
Publicado: (2020)

The Association between Out-of-Pocket Expenditure and COVID-19 Mortality Globally
por: El-Khatib, Ziad, et al.
Publicado: (2020)

Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
por: John, Teny M., et al.
Publicado: (2020)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

Corticosteroids in COVID-19: A double-edged sword – a retrospective study
por: Maia, R., et al.
Publicado: (2022)

SUCCESSFUL TREATMENT OF SEVERELY CHOLESTATIC ACUTE HEPATITIS B WITH ORAL CORTICOSTEROID
por: MALLICK, Bipadabhanjan, et al.
Publicado: (2020)

Use of corticosteroid injections in current COVID pandemic – Time to rethink!!
por: Rajakulasingam, Ramanan, et al.
Publicado: (2020)

Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy
por: Uzun, Serife, et al.
Publicado: (2021)

The COVID-19 pandemic and tuberculosis in Taiwan
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

A sound approach: Hydroxychloroquine reduces mortality in severe COVID-19
por: Zervos, Marcus, et al.
Publicado: (2020)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

A case of shock after 10 days systemic corticosteroid therapy for COVID-19
por: Uemura, Keiko, et al.
Publicado: (2021)

Thrombotic Events in COVID-19: Inquires About the Deleterious Procoagulant Effect of Corticosteroid Therapy
por: Crisan-Dabija, Radu, et al.
Publicado: (2021)

Early administration of corticosteroids and mortality
por: Sprung, Charles L, et al.
Publicado: (2012)

COVID-19 Vaccination and Usefulness in Prevention of Mortality Among the Elderly: An Analysis
por: Joob, Beuy, et al.
Publicado: (2023)

Increasing legionella in Taiwan during COVID-19 pandemic
por: Chao, Chien-Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c56k2ck8081sq4q2iiv8iq6mn8